Inhibition of inflammatory nitric oxide production and epidermis damages by Saccharomycopsis Ferment Filtrate.
BACKGROUND
Yeast extracts have been shown to perform anti-inflammatory and cytoprotective activities. However, the effects of yeast extracts on lipopolysaccharide (LPS)-induced nitric oxide (NO) production and epidermal damages are still unclear.


OBJECTIVE
To investigate the effect of Saccharomycopsis Ferment Filtrate (SFF) on LPS-induced NO production in RAW264.7 macrophages and epidermal damages.


METHODS
RAW264.7 cells are incubated with LPS (25 ng/mL) and different concentrations of SFF. The amount of NO production is detected by Griess reaction. Additionally, the expression of inducible nitric oxide synthase (iNOS) and heme oxygenase-1 (HO-1) are detected by Western blotting. Artificial epidermis is also used to mimic the in vivo condition to investigate the protective effects of SFF on LPS- or ultraviolet radiation (UVR)-induced damages by histology and electron microscopy.


RESULTS
The results show that SFF addition inhibits LPS-induced NO production and iNOS protein expression in a concentration-dependent manner without notable cytotoxicity in RAW264.7 cells, and induction of HO-1 protein expression by SFF was observed. Interestingly, both HO-1 inducers, hemin and CoCl2, significantly attenuated LPS-induced NO production and iNOS protein expression. The addition of CoCl2 potentiated the inhibitory effect of SFF on LPS-induced NO production. It seems that HO-1 protein participates in SFF inhibition of LPS-induced NO production. Furthermore, SFF exhibits significant protective effect on LPS- or UVR-induced damages in the artificial epidermis via histological and electron microscopic observations.


CONCLUSIONS
This study provided the first evidence to indicate the beneficial effects of SFF in preventing NO production in macrophages and damages in epidermis, respectively. It suggests that SFF possesses potential to be further developed.
Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan.
Hsiou-Hsin
HH
Tsai
Yen-Chou
YC
Chen
Woan-Ruoh
WR
Lee
Chung-Hong
CH
Hu
Tomohiro
T
Hakozaki
Takashi
T
Yoshii
Shing-Chuan
SC
Shen
D000818:Animals; D001688:Biological Products / Q000627:therapeutic use*; D002478:Cells, Cultured; D003035:Cobalt; D003872:Dermatitis / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D015870:Gene Expression; D051547:Heme Oxygenase-1 / Q000378:metabolism; D006427:Hemin; D006801:Humans; D007249:Inflammation / Q000628:therapy*; D008070:Lipopolysaccharides; D051379:Mice; D008954:Models, Biological; D009569:Nitric Oxide / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D012442:Saccharomycopsis; D012867:Skin / Q000528:radiation effects
D001688:Biological Products; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D003035:Cobalt; D006427:Hemin; D052247:Nitric Oxide Synthase Type II; D051547:Heme Oxygenase-1; C018021:cobaltous chloride